Search Results - steven selman

2 Results Sort By:
Engineered Protein Tames Bleeding In Haemophiliacs and Targets Angiogenesis in Cancer
Project ID: D2007-12 U.S. Patent #8,211,858; Canada, European patents pending U.S. Patent #7,592,422; Canada, France, Germany, Netherlands, UK patents pending Novelty: Modified plasminogen activator inhibitor type I (PAI- 1) with significantly increased in vivo half-life and decreased activity to urokinase plasminogen activator, tissue plasminog...
Novel Peptide for Treatment of Benign Prostate Hyperplasia
Project ID: D2009-47 Novelty: Use of a novel cyclic peptide L1AD3 as an injectable solution in the treatment of Benign Prostate Hyperplasia (BPH). Value proposition: The adverse effects and morbidities associated with the treatment options for BPH has led to the investigation into a number of minimally invasive alternatives such as utilization ...